Monday, 22 April 2024

Scivita Medical opens Headquarters, R&D and manufacturing plant in Suzhou Industrial Park

06 June 2023 | News

Scivita Medical has established R&D centres in both China and Japan, attracting many local talents in the field

China-based startup Scivita Medical's headquarters, R&D and manufacturing plant has been officially opened in Suzhou Industrial Park (SIP). This momentous occasion marks a significant milestone for Scivita Medical as it consolidates its key operations, encompassing R&D, production, marketing, doctor training, product display, and experiential activities.

The establishment of the plant will serve as a strong foundation for Scivita Medical to enhance its R&D capabilities as well as sales capabilities, further upgrade its production capacity and improve product competitiveness. It reflects Scivita Medical's commitment to its core strategy of "globalisation".

The main building, spanning four floors, encompasses functional areas including storage, offices, clean and non-clean workshop, with each area relatively independent from one another to ensure efficient and orderly production and operation. 

In addition, renovations for the professional training centre are set to commence by the end of 2023. It includes exhibition halls, conference centres, surgical training centres, and simulation training centres. This will be a strong support for Scivita Medical's ongoing efforts in cultivating the endoscope market. Internally, it will enhance employees' professional ability. Externally, it will improve doctors' awareness of the latest endoscope technologies and techniques. 

Furthermore, the new plant's office and production spaces feature functional sections, including the "Corridor Bar" and "Recreation Area," designed to provide employees with spaces for leisure and stress relief. 

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account